![Joseph J. Villafranca](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph J. Villafranca
President at Biopharmaceutical Consultants LLC
Profile
Joseph J.
Villafranca currently works at Anima Cell Metrology, Inc., as Director and Biopharmaceutical Consultants LLC, as President from 2012.
Dr. Villafranca also formerly worked at ImmunoGen, Inc., as Independent Director from 2004 to 2018, Tunnell Consulting, Inc., as Director & Senior Vice President-Operations from 2010 to 2012, Neose Technologies, Inc., as Executive Vice President-Operations from 2002 to 2005, The Pennsylvania State University, as Professor, Bristol-Myers Squibb World Wide Medicines Group, as Vice President-Biologics Strategy, and Biopharmaceutical Consultants LLC, as President from 2005 to 2006.
Dr. Villafranca received his doctorate degree from Purdue University and undergraduate degree from The State University of New York.
Joseph J. Villafranca active positions
Companies | Position | Start |
---|---|---|
Anima Cell Metrology, Inc.
![]() Anima Cell Metrology, Inc. Packaged SoftwareTechnology Services Anima Cell Metrology, Inc. engages in the development of novel technologies to monitor protein synthesis in living cells. The company was founded by Zeev Smilansky and is headquartered in Bernardsville, NJ. | Director/Board Member | 11/10/2010 |
Biopharmaceutical Consultants LLC | President | 01/05/2012 |
Former positions of Joseph J. Villafranca
Companies | Position | End |
---|---|---|
IMMUNOGEN, INC. | Director/Board Member | 20/06/2018 |
Tunnell Consulting, Inc.
![]() Tunnell Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Tunnell Consulting, Inc. provides technical, organizational and operational consulting services. It provides life sciences technical services, process and organizational excellence services, strategy and supply chain management services. The firm serves in the area of pharmaceutical, government and biotechnology departments. The company was founded in 1962 and is headquartered in King of Prussia, PA. | Chief Operating Officer | 17/11/2011 |
Biopharmaceutical Consultants LLC | President | 01/01/2006 |
Neose Technologies, Inc.
![]() Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | Chief Operating Officer | 31/10/2005 |
Bristol-Myers Squibb World Wide Medicines Group
![]() Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The company is based in Lawrenceville, NJ. | Corporate Officer/Principal | - |
Training of Joseph J. Villafranca
Purdue University | Doctorate Degree |
The State University of New York | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 6 |
---|---|
Neose Technologies, Inc.
![]() Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | Health Technology |
ImmunoGen, Inc.
![]() ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Tunnell Consulting, Inc.
![]() Tunnell Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Tunnell Consulting, Inc. provides technical, organizational and operational consulting services. It provides life sciences technical services, process and organizational excellence services, strategy and supply chain management services. The firm serves in the area of pharmaceutical, government and biotechnology departments. The company was founded in 1962 and is headquartered in King of Prussia, PA. | Commercial Services |
Biopharmaceutical Consultants LLC | |
Bristol-Myers Squibb World Wide Medicines Group
![]() Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The company is based in Lawrenceville, NJ. | Health Technology |
Anima Cell Metrology, Inc.
![]() Anima Cell Metrology, Inc. Packaged SoftwareTechnology Services Anima Cell Metrology, Inc. engages in the development of novel technologies to monitor protein synthesis in living cells. The company was founded by Zeev Smilansky and is headquartered in Bernardsville, NJ. | Technology Services |
- Stock Market
- Insiders
- Joseph J. Villafranca